Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
235 studies found for:    fluoxetine
Show Display Options
Rank Status Study
21 Recruiting Efficacy of Fluoxetine - a Trial in Stroke
Condition: Stroke
Interventions: Drug: Fluoxetine;   Drug: Placebo
22 Recruiting 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression
Condition: Bipolar Disorder
Interventions: Drug: Lamotrigine;   Drug: Fluoxetine
23 Completed Fluoxetine on Motor Rehabilitation After Ischemic Stroke
Conditions: Ischemic Stroke;   Motor Impairment
Interventions: Drug: fluoxetine;   Drug: placebo
24 Terminated Extended Management and Measurement of Autism
Condition: Autistic Disorder
Intervention: Drug: Fluoxetine (prozac)
25 Completed Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions
Condition: Healthy
Intervention: Drug: fluoxetine HCL 40 mg capsules
26 Withdrawn Fluoxetine Essay in Children With Autism
Condition: Autism
Interventions: Drug: fluoxetine;   Drug: placebo
27 Recruiting Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients
Conditions: Stroke;   Motor Function
Interventions: Device: Active Repetitive Transcranial Magnetic Stimulation (rTMS);   Drug: Fluoxetine;   Device: Sham repetitive transcranial magnetic stimulation (rTMS);   Drug: Placebo Fluoxetine
28 Completed Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
Conditions: Major Depressive Disorder;   Nicotine Dependence;   Depression
Interventions: Drug: Fluoxetine;   Drug: Dextrose
29 Completed Efficacy of Fluoxetine Against Seizure-induced Central Apneas
Conditions: Epilepsy;   Ictal/Post-ictal Hypoxemia
Interventions: Drug: fluoxetine 20 mg;   Drug: placebo 20 mg
30 Withdrawn Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic Stroke
Condition: Stroke
Interventions: Drug: fluoxetine;   Drug: placebo
31 Terminated Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
Condition: Obsessive-Compulsive Disorder
Interventions: Drug: Fluoxetine 60 mg;   Drug: Naltrexone 32 mg and fluoxetine 60 mg;   Drug: Naltrexone SR 32 mg
32 Completed
Has Results
A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
Condition: Major Depressive Disorder
Intervention: Drug: Fluoxetine
33 Recruiting Fluoxetine vs Aripiprazole Comparative Trial (FACT)
Condition: Attenuated Psychosis Syndrome
Interventions: Drug: Aripiprazole;   Drug: Fluoxetine
34 Completed
Has Results
Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa
Conditions: Anorexia Nervosa;   Eating Disorders
Interventions: Drug: Fluoxetine;   Drug: Placebo
35 Terminated Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage
Conditions: Intracerebral Hemorrhage;   Motor Impairment
Interventions: Drug: Fluoxetine;   Drug: Placebo
36 Completed
Has Results
Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
Condition: Premenstrual Syndrome
Interventions: Drug: Fluoxetine;   Drug: Calcium;   Drug: Placebo
37 Unknown  Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Fluoxetine + Valsartan;   Drug: Fluoxetine + Placebo
38 Terminated A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Condition: Treatment Resistant Depression
Interventions: Drug: Olanzapine;   Drug: Fluoxetine;   Drug: Placebo
39 Completed
Has Results
Pharmacological Intervention Project (Fluoxetine)
Conditions: Alcoholism;   Depression
Interventions: Drug: fluoxetine (Prozac);   Drug: Placebo plus Treatment As Usual
40 Enrolling by invitation Comparison of Acupuncture and Fluoxetine on Quality of Life in Menopausal Women
Conditions: Hot Flash;   Quality of Life
Interventions: Procedure: acupuncture;   Drug: fluoxetine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.